We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $22.1B
1-Year Est. Return 45.54%
This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
AUM
$20.7B
AUM Growth
-$166M
Cap. Flow
-$582M
Cap. Flow %
-2.82%
Top 10 Hldgs %
30.44%
Holding
2,896
New
52
Increased
415
Reduced
1,909
Closed
89

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$65.1M
2
AAPL icon
Apple
AAPL
+$58M
3
MSFT icon
Microsoft
MSFT
+$49.2M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$25.9M
5
AL
Air Lease Corp
AL
+$21.6M

Sector Composition

Rank Sector Weight
1 Technology 30.28%
2 Financials 13.29%
3 Healthcare 10.43%
4 Consumer Discretionary 10.39%
5 Industrials 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMPL icon
1376
Simply Good Foods
SMPL
$968M
$1.08M 0.01%
54,019
-1,933
-3% -$40.2K
RAMP icon
1377
LiveRamp
RAMP
$2.3B
$1.08M 0.01%
36,914
-1,861
-5% -$53.4K
CRGY icon
1378
Crescent Energy
CRGY
$3.93B
$1.08M 0.01%
129,127
+21,423
+20% +$188K
PK icon
1379
Park Hotels & Resorts
PK
$2.99B
$1.08M 0.01%
103,178
-5,108
-5% -$54.7K
EVTC icon
1380
Evertec
EVTC
$1.91B
$1.08M 0.01%
37,004
-1,420
-4% -$42.2K
SEI
1381
Solaris Energy Infrastructure
SEI
$3.94B
$1.08M 0.01%
23,392
+1,610
+7% +$77.9K
PGNY icon
1382
Progyny
PGNY
$1.99B
$1.07M 0.01%
41,754
-1,820
-4% -$41.9K
NTCT icon
1383
NETSCOUT
NTCT
$2.89B
$1.07M 0.01%
39,554
-1,758
-4% -$47.5K
DKNG icon
1384
DraftKings
DKNG
$12.6B
$1.07M 0.01%
31,040
+269
+0.9% +$8.85K
STC icon
1385
Stewart Information Services
STC
$2B
$1.07M 0.01%
15,218
-1,117
-7% -$80.4K
LION icon
1386
Lionsgate Studios
LION
$3.49B
$1.07M 0.01%
116,978
-3,514
-3% -$25K
ATRC icon
1387
AtriCure
ATRC
$2.22B
$1.07M 0.01%
26,954
-1,342
-5% -$49.2K
AUPH icon
1388
Aurinia Pharmaceuticals
AUPH
$2.02B
$1.06M 0.01%
66,628
-4,192
-6% -$59.4K
TOST icon
1389
Toast
TOST
$20.4B
$1.06M 0.01%
29,915
+993
+3% +$35.8K
HMN icon
1390
Horace Mann Educators
HMN
$2.09B
$1.06M 0.01%
22,972
-1,638
-7% -$74.1K
TWST icon
1391
Twist Bioscience
TWST
$7.86B
$1.05M 0.01%
33,236
-1,491
-4% -$46.5K
AORT icon
1392
Artivion
AORT
$1.39B
$1.05M 0.01%
23,056
+606
+3% +$27K
MD icon
1393
Pediatrix Medical
MD
$2.15B
$1.05M 0.01%
49,126
-3,361
-6% -$68.9K
NRIX icon
1394
Nurix Therapeutics
NRIX
$2.76B
$1.05M 0.01%
55,345
+10,127
+22% +$145K
KN icon
1395
Knowles
KN
$3.23B
$1.05M 0.01%
48,951
-2,484
-5% -$56.6K
YELP icon
1396
Yelp
YELP
$1.28B
$1.05M 0.01%
34,495
-2,403
-7% -$74.1K
SNDX icon
1397
Syndax Pharmaceuticals
SNDX
$1.77B
$1.04M 0.01%
49,732
KALU icon
1398
Kaiser Aluminum
KALU
$2.99B
$1.04M 0.01%
9,083
-463
-5% -$44.1K
PRGS icon
1399
Progress Software
PRGS
$1.79B
$1.04M 0.01%
24,269
-1,084
-4% -$47.2K
BUR icon
1400
Burford Capital
BUR
$968M
$1.04M 0.01%
116,817

Similar funds

MetLife Investment Management's Q4 2025 Portfolio in Review

As of Q4 2025, MetLife Investment Management held 2,896 positions worth $20.7B, down 0.8% from $20.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q4 2025: portfolio turnover was 4.9%. MetLife Investment Management opened 52 new positions and exited 89, leaving the 2,896-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q4 2025 buy was RTX Corp: 321,368 shares worth $58.9M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $54.6M increase.
  • MetLife Investment Management's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $65.1M.
  • MetLife Investment Management fully exited Kellanova in Q4 2025, selling an estimated $5.48M.
  • MetLife Investment Management's ten largest holdings make up 30% of its $20.7B portfolio in Q4 2025.
  • MetLife Investment Management opened 52 new positions and closed 89 in Q4 2025.
  • MetLife Investment Management's portfolio value fell 0.8% quarter-over-quarter to $20.7B.

Based on MetLife Investment Management's 13F filing for Q4 2025, filed 12 Feb 2026.